By Joel Scanlon
Glycos Biotechnologies, (GlycosBio), a global biochemical company marketing valuable and renewable specialty chemicals, declared that it has selected Toyo Engineering & Construction (Toyo Malaysia) to offer procurement, engineering and construction (EPC) services for its Johor, Malaysia-based industrial biochemical production facility.
GlycosBio’s commercial facility will be built inside a biotechnology park, Bio-XCell. GlycosBio’s plant building will be done by the second quarter of 2013.
GlycosBio’s President, Walt Burnap, teamed together with executives from Toyo and Bio-XCell like Toji Kawakami, Managing Director Toyo Malaysia and Rizatuddin Ramli, CEO of Bio-XCell at an event held on December 6th in Malaysia.
The facility will be built in a number of phases with 30,000 Mt production rate capacity per year expected to be attained by 2014 with a subsequent increase up to 90,000 Mt. Isoprene, used in the synthetic rubber market is the targeted biochemical for GlycosBio’s plant. The company will initially be focused on validating its capability for industrial ethanol production from crude glycerin and further interested in using different feedstocks comprising fatty acids. GlycosBio’s complete production facility attributes to isoprene production from cheap, renewable feedstocks that can be obtained easily in Malaysia.
GlycosBio, through its affiliation with Bio-XCell, first revealed its interest in 2010 to expand to Malaysia and will be the first US-based company at the industrial park in Johor, Malaysia. GlycosBio is a recipient of BioNexus status in 2011, qualified by the Malaysian Government to support the advancement of biotechnology.